About Us

RA Capital Swiftbridge is a China-based clinical development accelerator built exclusively for RA Capital Management, RA Capital’s healthcare incubator Raven, and its partners. We help companies design smarter clinical programs, access the right infrastructure and patients, and generate key data faster. 

RA Capital Swiftbridge comprises a dedicated, China-based team of experienced leaders across discovery, preclinical development, clinical development, clinical operations, strategic advisory, and alliance management. Our goal is not simply faster enrollment; it’s creating decision-quality clinical evidence earlier, in populations and care pathways that may be difficult to recruit or do not exist in the West. We believe that innovation is global, just like the diseases we fight.